A detailed history of National Asset Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, National Asset Management, Inc. holds 11,417 shares of BSX stock, worth $1.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,417
Previous 16,270 29.83%
Holding current value
$1.03 Million
Previous $1.11 Million 21.1%
% of portfolio
0.02%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$67.33 - $77.71 $326,752 - $377,126
-4,853 Reduced 29.83%
11,417 $879,000
Q1 2024

May 16, 2024

BUY
$57.6 - $68.62 $320,486 - $381,801
5,564 Added 51.97%
16,270 $1.11 Million
Q4 2023

Mar 15, 2024

SELL
$48.64 - $57.81 $270,632 - $321,654
-5,564 Reduced 34.2%
10,706 $618,000
Q3 2023

Dec 01, 2023

SELL
$50.19 - $54.68 $1.27 Million - $1.38 Million
-25,223 Reduced 60.79%
16,270 $859,000
Q2 2023

Jul 27, 2023

BUY
$49.72 - $54.64 $1.45 Million - $1.59 Million
29,159 Added 236.41%
41,493 $2.24 Million
Q1 2023

May 17, 2023

BUY
$45.09 - $50.03 $38,822 - $43,075
861 Added 7.5%
12,334 $617,000
Q4 2022

Feb 21, 2023

BUY
$39.56 - $47.22 $39,599 - $47,267
1,001 Added 9.56%
11,473 $530,000
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $30,762 - $91,895
838 Added 8.7%
10,472 $407,000
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $7,541 - $10,079
214 Added 2.27%
9,634 $360,000
Q1 2022

May 02, 2022

BUY
$40.9 - $45.1 $51,084 - $56,329
1,249 Added 15.29%
9,420 $418,000
Q4 2021

Jan 28, 2022

SELL
$38.07 - $44.87 $7,195 - $8,480
-189 Reduced 2.26%
8,171 $348,000
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $27,665 - $30,785
671 Added 8.73%
8,360 $362,000
Q2 2021

Aug 10, 2021

SELL
$38.58 - $44.24 $5,709 - $6,547
-148 Reduced 1.89%
7,689 $323,000
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $276,410 - $310,893
7,837 New
7,837 $302,000
Q4 2020

Feb 04, 2021

SELL
$33.15 - $41.97 $391,037 - $495,078
-11,796 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$34.44 - $42.23 $406,254 - $498,145
11,796 New
11,796 $448,000
Q1 2020

May 06, 2020

SELL
$25.83 - $45.71 $114,685 - $202,952
-4,440 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$37.87 - $45.37 $256,228 - $306,973
-6,766 Reduced 60.38%
4,440 $202,000
Q3 2019

Nov 12, 2019

BUY
$40.31 - $43.45 $25,999 - $28,025
645 Added 6.11%
11,206 $457,000
Q2 2019

Aug 05, 2019

BUY
$34.91 - $42.98 $109,198 - $134,441
3,128 Added 42.08%
10,561 $455,000
Q1 2019

May 08, 2019

SELL
$32.91 - $40.75 $218,785 - $270,906
-6,648 Reduced 47.21%
7,433 $286,000
Q4 2018

Feb 08, 2019

SELL
$31.73 - $39.04 $4,949 - $6,090
-156 Reduced 1.1%
14,081 $499,000
Q3 2018

Nov 08, 2018

BUY
$32.83 - $38.63 $467,400 - $549,975
14,237 New
14,237 $549,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.